Next Article in Journal
Synthesis of New Cyano-Substituted bis-Benzothiazolyl Arylfurans and Arylthiophenes
Previous Article in Journal
The Use of 4-(3,4-Dichlorophenyl)-4-Oxo-2-(4-Antipyrinyl)-Butanoic Acid in the Preparation of Some New Heterocyclic Compounds With Expected Biological Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Routes to Pyridino[2,3-d]pyrimidin-4-one and Pyridino-[2,3-d]triazolino[4,5-a]pyrimidin-5-one Derivatives

by
Hamdi M. Hassneen
* and
Tayseer A. Abdallah
Department of Chemistry, Faculty of Science, University of Cairo, Giza, Egypt
*
Author to whom correspondence should be addressed.
Molecules 2003, 8(3), 333-341; https://doi.org/10.3390/80300333
Submission received: 2 December 2002 / Revised: 13 January 2003 / Accepted: 9 January 2003 / Published: 31 March 2003

Abstract

:
2-Thioxopyrimidinyl-5-(N,N-dimethylamino)formamidine  (5) and 1,3-diphenyltriazolo[3,4-d]pyrimidinyl-N,N-dimethylformamidine (14) were prepared by condensation of 6-amino-2-thioxo-1,3-dihydropyrimidin-4-one (2) and 7-amino-1,3-diphenyl-1,2,4-triazolo[4,3-a]pyrimidin-4-one (13) with dimethylformamide dimethyl- acetal (DMFDMA). Compound 5 reacts with acetophenone and 2-acetylthiophene to give the 2-thioxo-1,3-dihydropyridino[2,3-d]pyrimidin-4-ones 3a and 3b, respectively. Compounds 3a,b react with hydrazonoyl halides 6,7 to give pyridino[2,3-d]triazolo[4,5-a]pyrimidin-4-ones 11a-d and not the isomeric structures 12a-d. Formamidines of type 14 react with ethyl cyanoacetate, malononitrile and benzoyl acetonitrile to give the 1,3-diphenyl-3a-hydropyridino[2,3-d]1,2,4-triazolo[4,5-a]pyrimidin-4-one derivatives 15a,b and 18, respectively. The structures of the newly synthesized compounds are established on the basis of chemical and spectroscopic evidences as well as their synthesis by alternative methods.

Introduction

Azoloazine derivatives form a very interesting class of compounds because of their significant biological and pharmaceutical activities and their chemistry is consequently now receiving considerable attention [1,2,3,4]. As part of our studies aimed at developing simple and efficient syntheses of polyfunctional heteroaromatics from readily obtained starting materials [5,6,7,8,9,10]. We now wish to report the reaction of pyridino[2,3-d]pyrimidines 3 with hydrazonoyl halides 6,7 to give novel functionalized heterocycles having pyridine rings condensed with other important heterocycles such as pyrimidines and triazolopyrimidines. In many cases, however, the exact structure of the reaction products could not be established unequivocally, because several close similar isomeric products could conceivably be formed. In this paper, we report the synthesis of heterocyclic compounds 3, 5, 11, 14, 15 and 18 and the confirmation of the structures of the resulting products by spectroscopic data as well as their synthesis by alternative methods. The newly synthesized compounds appear to be promising substrates for further chemical transformations as well as biological activity evaluations.

Results and Discussion

Enaminones 1a,b were prepared by reaction of dimethylformamide dimethylacetal (DMFDMA) with acetophenone and 2-acetylthiophene in refluxing dioxane (Scheme 1), as previously described [11].
Scheme 1.
Scheme 1.
Molecules 08 00333 g001
Enaminones 1a,b condensed readily with 6-amino-2-thioxopyrimidin-4(3H)one (2) [12] in boiling acetic acid to give either pyridino[2,3-d]pyrimidine derivatives 3a,b or the isomeric structures 4a,b in high yields (Scheme 1). The 1H-NMR spectra of the resulting products displayed four signals readily recognizable as arising from two CH (δ 7.91, 8.63) and two NH groups (δ 12.62, 13.17), along with the multiplet in the aromatic region. Their IR spectra revealed the absence of the bands corresponding to the amino group. Elemental analysis and mass spectra agreed equally with both structures 3 and 4. These data alone cannot determine the exact structures of the resulting products therefore conclusive evidence for the structures was obtained by synthesis of 3a,b via reactions of N,N- dimethylaminoformamidine 5 with acetophenone and 2-acetylthiophene, respectively (Scheme 1).
Scheme 2.
Scheme 2.
Molecules 08 00333 g002
The required intermediate 5 was obtained by condensation of 2 with DMFDMA in boiling dioxane (Scheme 1). The 1H-NMR spectrum of 5 displayed six singlets recognizable as arising from the two methyls (δ 2.99, 3.11), the CH=N- (δ 5.24), the CH of the pyrimidine ring at δ 8.14 and two NH groups at δ 11.61 and 11.79 ppm. Structure 5 was further confirmed by its mass spectrum, which gave an intense molecular ion peak at m/z 198.
Treatment of 3a,b with hydrazonoyl chlorides 6 and 7 in boiling chloroform in the presence of triethylamine led to the formation of either 11a-d or the isomeric structures 12a-d (Scheme 2). Structures 11a-d could be established for these products based on their alternate syntheses. For example, formamidine 14 reacts with acetophenone in boiling glacial acetic acid to give a product which was found to be identical in all respects (mp, mixed mp, IR, 1H-NMR) with structure 11a. The structure assignments of 11a-d were also supported by spectroscopic data. For example, the 1H-NMR spectra revealed the absence of the signals corresponding to the N,N-dimethylaminoformamidine group, instead it showed two doublets at 7.91, 8.63 corresponding to protons at positions 7,8 in the pyridine ring. Compound 14 was obtained by condensation of 7-amino-1,3-diphenyl-1,2,4-triazolo[4,3-a]pyrimidin-5-one (13), prepared via dipolar cycloaddition of 2 with hydrazonoyl halide 6 in chloroform in the presence of triethylamine, with DMFDMA (Scheme 2).
The structure of 14 was confirmed by elemental analysis and spectroscopic data (IR, 1H-NMR, 13C-NMR, mass spectra). For example, the mass spectrum gave an intense molecular peak at m/z 358. The 1H-NMR spectrum showed the characteristic signals of N,N-dimethylformamidine group at δ 3.14 (s, 3H), 3.15 (s, 3H), 5.66 (s, 1H) in addition to a multiplet in the aromatic region. The 13C-NMR spectra of 14 revealed two sp3 carbons, which can be assigned to the two methyl groups at δ 35.61, and 41.80 and a signal at δ 91.80 assigned to the N=CH, in addition to the carbon atoms in the aromatic system. The versatile compound 14 can also allow the synthesis of condensed pyridino[2,3- d]triazolo[4,5-a]pyrimidin-4-ones. To demonstrate its potential, 14 was reacted with ethyl cyanoacetate and malononitrile in boiling glacial acetic acid to yield products of condensation 15a,b by elimination of dimethylamine and then cyclization (Scheme 3).
Scheme 3.
Scheme 3.
Molecules 08 00333 g003
The mass spectra of the products showed intense peaks at m/z 426 and 379 assignable to the molecular ion peaks of the compounds 15a and 15b, respectively. The 1H-NMR spectrum of 15a indicated the disappearance of the protons from the N,N-dimethylformamidine group, and instead showed a triplet at δ 1.29 (3H) and a quartet at 4.20 ppm (2H), assigned to ethoxycarbonyl group. The structures of the products were also confirmed by their alternative synthesis via reaction of 13 with enaminones 17a and 17b, respectively. Despite the fact that heterocyclic amines are well known to exist preferentially in the amino rather than the imine form, compounds 15a and 15b exist mainly, at least in DMSO solution, in the imine form (Scheme 4). This was confirmed by their 1H-NMR spectra which revealed two signals for two NH groups at about δ 5.68 and 11.73 ppm (1H each) which disappeared on shaking with deuterium oxide.
Scheme 4.
Scheme 4.
Molecules 08 00333 g004
Compound 14 also reacts under similar conditions with benzoylacetonitrile to give the condensation product 18 by elimination of dimethylamine and water (Scheme 5). The mass spectrum of the product gave an intense peak at m/z 440 corresponding to the expected molecular ion peak of 18. The structure was also confirmed by its alternative synthesis from 19 and 13 (Scheme 5).
Scheme 5.
Scheme 5.
Molecules 08 00333 g005
In conclusion, the have reported the preparation of readily obtainable formamidines that are valuable precursors for the synthesis of a variety of heteroaromatics of potential interest for biological evaluation.

Experimental

General

All melting points are uncorrected. IR spectra (KBr pellets) were recorded with a Pye Unicam SP- 3000 IR spectrophotometer. NMR spectra were determined on a Varian Gemini 200 spectrometer using DMSO-d6 as solvent and TMS as internal standard; chemical shifts are reported in δ units (ppm). Mass spectra were measured at 70eV using a Shimadzu GCMS-QP 1000 EX instrument. Microanalyses were performed on a Perkin-Elemer 2400 CHN Elemental Analyzer at the University of Cairo Microanalytical Center. Compounds 6 [13], 7 [14, 13 [15] were prepared following published procedures. Unless stated otherwise standard workups consisted of allowing the reaction mixtures to cool, collecting the precipitates formed and recrystallizing them from dimethylformamide (DMF). The analytical and spectral data of compounds prepared is summarized in Table 1 and Table 2.
General Procedures for the Synthesis of 2-Thioxo-1,3-dihydropyridino[2,3-d]pyrimidin-4-ones (3a,b).
Method A. Enaminones 1a,b (0.001 mol) were refluxed with 2 (1.43 g, 0.001 mol) in glacial acetic acid (20 mL) for 2h to give compounds 3a,b after the standard workup.
Method B. Formamidine 5 (1.98 g, 0.001 mol) was refluxed with 2-acetylthiophene (1.26 g, 0.001 mol) or acetophenone (1.20 g, 0.001 mol) in glacial acetic acid (10 mL) for 2h. The products were identical in all respects (mp, mixed mp, IR) to those prepared by method A.
Synthesis of 2-thioxopyrimidinyl-5-(N,N-dimethylamino)formamidine (5)
A mixture of 2 (1.47 g, 0.001 mol) and DMFDMA (1.19 g, 0.012 mol) was refluxed in dioxane (25 mL) for 3h. The reaction mixture was then cooled to room temperature and the product was collected and crystallized from DMSO.
General Procedure for the Synthesis of Pyridino[2,3-d]1,2,4-triazolo[4,3-a]pyrimidin-4-ones (11a-d)
Method A: To a mixture of compound 3 (0.005 mol) and hydrazonoyl halides 6,7 (0.005 mol) in chloroform (40 mL) triethylamine (0.7 mL, 0.005 mol) was added. The reaction mixture was refluxed until the hydrazonoyl halides disappeared (4-6 h) as indicated by TLC analysis. The solvent was evaporated under reduced pressure and the residue was treated with methanol (10 mL).
Method B: A mixture of formamidine 14 (1.79 g, 0.005 mol) and 2-acetylthiophene (1.26 g, 0.005 mol) or acetophenone (1.2 g, 0.005 mol) was refluxed in acetic acid for 3 h to give 11a,b, identical in all respects (mp, mixed mp, IR) to that prepared by Method A.
Synthesis of 1,3-diphenyltriazolo[3,4-d]pyrimidinyl-N,N-dimethylformamidine (14)
7-Amino-1,3-diphenyl-1,2,4-triazolo[4,3-a]pyrimidine-5-one (13, 1.51 g, 0.005 mol) was refluxed in DMFDMA (10 mL) for 3h.
General Procedure for the Synthesis of Pyridino[2,3-d]triazolo[4,5-a]pyrimidin-5-ones (15,18).
A solution of 14 (1.79 g, 0.005 mol) and a nitrile compound (0.005 mol) was refluxed in acetic acid (10 mL) for 2h.
Table 1. Analytical data of the synthesized compounds
Table 1. Analytical data of the synthesized compounds
Compd. no.ColorYield (%)m.p. °C solventMol. formula (Mol. Wt)Analysis Calcd (Found)
CHNS
3ayellowish75260-261C13H9N3OS61.153.5516.4712.54
white DMF255.1061.403.7116.5312.59
3byellow80254-255C11H7N3OS250.562.7016.0924.51
DMF261.0850.542.5216.3724.45
5yellow85339-341C7H10N4OS42.405.0828.2816.15
DMSO198.1142.495.1528.3616.33
11Acolorless78281-282C26H17N5O75.154.1216.86
DMF415.1975.254.2317.06
11Byellowish80287-289C24H15N5OS68.383.5816.627.59
white DMF421.1761.313.7416.527.36
11Cyellow76286-288C23H17N5O367.124.1617.03
DMF411.1967.254.0817.29
11Dyellow75216-218C21H15N5O3S60.413.6216.787.67
DMF417.1760.263.4016.637.82
14colorless90208-209C20H18N6O67.005.0623.46
DMF358.2067.245.3523.58
15ayellow75350-352C23H18N6O364.764.2519.71
DMF426.2064.734.2119.86
15bcolorless80335-337C21H13N7O66.463.4525.85
DMF379.1766.783.6225.70
18yellowish82327-328C27H16N6O73.613.6619.09
whiteDMF440.1973.793.5119.24
Table 2. Spectroscopic data of synthesized compounds
Table 2. Spectroscopic data of synthesized compounds
Compd. no.IR (ν/cm-1)M+1H-NMR (δ/ppm)
3a1686 (CO), 3255 (NH)2557.56-7.59 (m, 3H, aromatic-H), 7.91 (d, 1H, pyridine), 8.18-8.22 (m, 2H, aromatic-H), 8.63 (d, 1H, pyridine), 12.62 (s, 1H, NH), 13.17 (s, 1H, NH).
3b1680 (CO), 3343 (NH)2617.25-9.22 (m, 5H, aromatic-H), 12.86 (s, 1H, NH), 13.32 (s, 1H, NH).
51648 (CO), 3256 (NH)1982.99 (s, 3H, CH3); 3.11 (s, 3H, CH3), 5.24 (s, 1H, N=CH), 8.14 (s, 1H, pyrimidine), 11.61 (s, 1H, NH), 11.79 (s, 1H, NH).
11a1710 (CO)4157.88 (d, 1H, pyridine); 7.56-8.00 (m, 15H, aromatic-H); 8.63 (d, 1H, pyridine).
11b1702 (CO)4217.23-8.49 (m, 13H, aromatic-H); 7.91 (d, 1H, pyridine); 8.73 (d, 1H, pyridine).
11c1715 (CO) 1720 (ester CO)4111.42 (t, J = 7Hz, 3H, CH3); 4.25 (q, J = 7Hz, 2H, CH2); 7.21-8.24 (m, 10H, aromatic-H); 7.72 (d, 1H, pyridine), 8.50 (d, 1H, pyridine).
11d1700 (CO), 1715 (ester CO)4171.41 (t, J = 7 Hz, 3H, CH33), 4.28 (q, J = 7 Hz, 2H, CH2), 7.73 (d, 1H, pyridine-H), 5.45-8.11 (m, 8H, aromatic-H), 8.55 (d, 1H, pyridine-H).
141702 (CO)3583.14 (s, 3H, CH3), 3.15 (s, 3H, CH3), 5.66 (s, 1H, N=CH), 7.21-8.40 (m, 10H, aromatic H), 8.59 (s, 1H, pyrimidine H-6).
15a1690 (CO), 1715 (ester CO)4261.29 (t, J=7Hz, 3H, CH3), 4.20 (q, J= 7Hz, 2H, CH2), 5.85 (s, 1H, NH), 7.46-8.10 (m, 10H, aromatic-H), 8.92 (s, 1H, pyridine), 11.78 (s, 1H, NH).
15b1720 (CO), 2229 (CN), 3193, 3400 (2 NH)3375.68 (s, 1H, NH), 7.47-8.17 (m, 10H, aromatic-H), 8.66 (s, 1H, pyridine), 11.73 (s, 1H, NH).
181728 (CO), 2221 (CN)4407.48-8.29 (m, 15H, aromatic-H); 9.15 (s, 1H, pyridine)
13C-NMR data (δ, DMSO-d6): (5): 167.27 (CO), 160.94 (CS), 163.35, 158.31, 96.48 (N=CH), 36.17 (CH3), 14.48 (CH3); (14): 168.37 (CO), 158.82, 157.44, 148.89, 145.72, 137.78, 131.17, 129.89, 129.65, 128.23, 127.40, 127.00, 121.44, 91.80 (N=CH), 41.80 (CH3), 35.61 (CH3); (15a): 165.44 (CO), 158.33(CO), 158.58, 151.60, 149.89, 146.59, 137.91, 133.32, 131.03, 129.44, 129.33, 127.74, 122.89, 116.62, 87.69, 80.78, 77.22, 62.79 (CH2), 15.95(CH3)

References

  1. Elnagdi, M. H.; Al-Awdi, N.; Erian, A.W. Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Rees, C. W., Scriven, E. F. V., Eds.; Pergamon Press: London, 1996; Vol 4, p. 431. [Google Scholar]
  2. Desenko, S. V.; Komykhov, S. A.; Orlov, V. D.; Meier, H. J Hetrocyclic Chem. 1998, 35, 989.
  3. Quiroga, J.; Insuasty, B.; Graz, S.; Hernandez, P.; Bolafios, A.; Moreno, R.; Hormoza, A.; de Almeidas, H. J Heterocyclic Chem 1998, 35, 1333.
  4. Greenhill, J. V. Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Rees, C. W., Eds.; Pergamon Press: London, 1984; Vol 5, p. 305. [Google Scholar]
  5. Abdelhadi, H. A.; Elwan, N. M.; Abdallah, T. A.; Hassaneen, H. M. Tetrahedron 1996, 52, 3451.
  6. Hassaneen, H. M.; Abdelhadi, H. A.; Abdallah, T. A. Tetrahedron 2001, 57, 10133.
  7. Abdelhadi, H. A.; Abdallah, T. A.; Hassaneen, H. M. Heterocycles 1995, 41, 1999.
  8. Abdallah, T. A.; Abdelhadi, H. A.; Ibrahim, A. A.; Hassaneen, H. M. Synth Comm 2002, 32, 581.
  9. Awad, E. M.; Elwan, N. M.; Hassaneen, H. M.; Linden, A.; Heimgartner, H. Helv Chim Acta 2002, 85, 320.
  10. Awad, E. M.; Elwan, N. M.; Hassaneen, H. M.; Linden, A.; Heimgartner, H. Helv Chim Acta 2001, 84, 1172.
  11. Al–Omran, F.; Abdelkhalik, M. M.; Elnagdi, M. H. Heteroatom Chem 1995, 6, 545.
  12. Hübsch, W.; Pfleiderer, W. Helv Chim Acta 1988, 71, 1379.
  13. Wolkof, P. Can. J.Chem. 1975, 53, 1333.
  14. Eweiss, N. F.; Abdelhamid, A. O. J.Heterocycl Chem. 1980, 17, 1713.
  15. Mosselhi, A. N. Monatsh Chem. 2002, 133, 1297.
  • Sample availability: Samples not available.

Share and Cite

MDPI and ACS Style

Hassneen, H.M.; Abdallah, T.A. New Routes to Pyridino[2,3-d]pyrimidin-4-one and Pyridino-[2,3-d]triazolino[4,5-a]pyrimidin-5-one Derivatives. Molecules 2003, 8, 333-341. https://doi.org/10.3390/80300333

AMA Style

Hassneen HM, Abdallah TA. New Routes to Pyridino[2,3-d]pyrimidin-4-one and Pyridino-[2,3-d]triazolino[4,5-a]pyrimidin-5-one Derivatives. Molecules. 2003; 8(3):333-341. https://doi.org/10.3390/80300333

Chicago/Turabian Style

Hassneen, Hamdi M., and Tayseer A. Abdallah. 2003. "New Routes to Pyridino[2,3-d]pyrimidin-4-one and Pyridino-[2,3-d]triazolino[4,5-a]pyrimidin-5-one Derivatives" Molecules 8, no. 3: 333-341. https://doi.org/10.3390/80300333

Article Metrics

Back to TopTop